Difference between revisions of "Apligraf"
Jump to navigation
Jump to search
(Created page with "{{Construction Site}} right|thumb| Apligraf is a synthetic skin created from harvested foreskins.<ref> {{cite web | url = http://www.apligraf.com...") |
m |
||
Line 1: | Line 1: | ||
− | {{ | + | <!-- [[Image:Alloderm-logo.jpg|right|thumb|]] --> |
+ | Apligraf is a synthetic skin created from harvested foreskins.<ref>{{REFwebQuote | ||
+ | | quote=Human keratinocytes and fibroblasts are derived from neonatal foreskins | ||
+ | | last= | ||
+ | | first= | ||
+ | | publisher=Organogenesis | ||
+ | | year= | ||
+ | | urltitle=Apligraf: How Is It Made? | ||
+ | | url=http://www.apligraf.com/professional/what_is_apligraf/how_is_it_made/ | ||
+ | | accessdate=2011-03-06 | ||
+ | }}</ref> It is [[FDA]] approved,<ref>{{REFwebQuote | ||
+ | | quote=Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998). | ||
+ | | last= | ||
+ | | first= | ||
+ | | publisher=Organogenesis | ||
+ | | year= | ||
+ | | urltitle=Apligraf | ||
+ | | url=http://www.organogenesis.com/products/bioactive_woundhealing/apligraf.html | ||
+ | | accessdate=2011-03-06 | ||
+ | }}</ref> and it is made and sold by [[Organogenesis]], which a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf. | ||
− | + | == Apligraph Oral == | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | + | Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref>{{REFnews | |
− | + | | last= | |
− | Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref> {{ | + | | first= |
+ | | coauthors= | ||
+ | | url=http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdf | ||
+ | | title=November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript | ||
+ | | date=November 2011 | ||
+ | | publisher=FDA | ||
+ | | quote= | ||
+ | | accessdate=2011-12-20 | ||
+ | }}</ref> | ||
Sponsor slides: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/cellulartissueandgenetherapiesadvisorycommittee/ucm284480.pdf | Sponsor slides: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/cellulartissueandgenetherapiesadvisorycommittee/ucm284480.pdf | ||
− | + | {{REF}} | |
− | |||
− | |||
− | |||
[[Category:Foreskin Products]] | [[Category:Foreskin Products]] |
Revision as of 13:12, 18 August 2019
Apligraf is a synthetic skin created from harvested foreskins.[1] It is FDA approved,[2] and it is made and sold by Organogenesis, which a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.
Apligraph Oral
Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."[3]
References
- ↑ Template:REFwebQuote
- ↑ Template:REFwebQuote
- ↑ (error)."November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript", FDA. Retrieved 20 December 2011.